Researchers have developed a new bowel cancer blood test they believe could save lives. The University of Essex said the ...

A new blood test has an 80% accuracy in predicting preterm ... Labs have been able to extract cell-free DNA, sequence it and use the sample to screen for fetal abnormalities such as Down syndrome.

Karius has developed a cell-free-DNA-based diagnostic test capable of identifying bacteria, mycobacteria, DNA viruses, fungi and protozoa in the blood down to the species level, thereby rapidly ...

The test developed by Quake’s team was more accurate than ... At the time, some researchers were trying to isolate fetal “cell-free DNA” from the mother’s blood. Cell-free DNA is fragmented ...

et al. Direct detection and quantification of bacterial cell-free DNA in patients with bloodstream infection (BSI) using the Karius plasma next generation sequencing (NGS) test. Open Forum Infect.

Donor-derived cell-free DNA can aid detection, diagnosis, and monitoring of antibody-mediated rejection after kidney transplantation. Donor-derived cell-free DNA (dd-cfDNA) is a non-invasive ...

With a flexible, no-equipment-needed platform, ChBE researchers are creating a new way to test for disease at home or anywhere medical resources are limited. The team's modular cell-free protein ...

Discover the price reduction of ENFINIA™ DNA products by 25%, improving access to high-quality DNA for researchers.

AUSTIN, Texas, February 25, 2025--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced that its Signatera test has met coverage ...

The test is available for clinical and research ... About Natera Natera™ is a global leader in cell-free DNA and genetic testing, dedicated to oncology, women’s health, and organ health.

The test was created by interfacing nanomechanical ... which were configured to control gene expression in a cell-free reaction by binding and unbinding DNA. During the coronavirus pandemic ...